Skip to content
Open Imaging Index
LicenseRef-ASPREE-Data-Use-Policy ยท custom agreement

ASPREE Data Use Policy

ASPREE data go only to project proposals approved by the ASPREE International Executive Committee, with ethics approval and a signed memorandum of understanding; sub-study data also need the sub-study principal investigator's approval. Data stay in the ASPREE Safe Haven by default, and draft manuscripts are reviewed by the committee.

Original license text Edit Purpose: Approved project only Version read: Version 1.0, 21 May 2020 Checked 2026-10-08
GA4GH DUO: PSIRB

Our reading of the license, not legal advice. Before you use the data, read the original license and confirm that your use is allowed. We take no responsibility for how you use a dataset. Full disclaimer

In your favor With conditions Restricts you Not stated in the text

What you can do

  • Not stated
  • Not stated
  • Not stated
  • Conditional

What you can share

  • No
  • Not stated
  • Share trained models Not stated

What you must do

  • Not stated
  • Share alike No
  • Yes
  • Yes
  • Yes
  • Release code No
  • Return results No
  • Delete after use No

Limits

  • No
  • No

Datasets under this license

  • ASPREE-NEURO

    Longitudinal 3 T brain MRI (T1w, FLAIR, SWI, diffusion, ASL, resting-state fMRI) of 559 healthy Australians aged 70 and over in a randomised aspirin trial, scanned at baseline, 1 and 3 years to track microbleeds and white matter lesions. Access by ASPREE application.